WebEvelio Rubio Ferdinand’s Post Evelio Rubio Ferdinand MS Medical Manager South Cone at Sanofi Genzyme WebApr 24, 2012 · Sormani et al. 1 claim to have validated individual-level surrogacy of MRI lesions/relapses for Expanded Disability Status Scale (EDSS) worsening. However, the outcome measures (greater than 1 EDSS point change over 2 years) used during PRISMS are mostly if not entirely noise, and do not relate to true unremitting disability. 2 The …
Did you know?
WebMaría Marcela Schmid1, Susana Roverano2, Mónica Sacnun3, Anabel Ledda4, Geoffrey Earsman5, Graciela Grosso6, Juan Barreira7, Edson Veloso8, Graciela Rodríguez9, Sergio Paira10 1Sección de Reumatología, Hospital J.M. Cullen, Santa Fe (Argentina). 2Sección de Reumatología, Hospital J.M. Cullen, Santa Fe (Argentina). 3Rosario, Santa Fe … WebApr 13, 2024 · Background. Hospitalized patients with coronavirus disease 2024 (COVID-19) can be classified into different clinical phenotypes based on their demographic, clinical, radiology, and laboratory features [Citation 1–7].Based on data from the first phase of the COVID-19 pandemic, Gutierrez-Gutierrez and colleagues identified three distinct clinical …
WebNeurologists diagnose and treat disorders of the brain, spinal cord, peripheral nerves, muscles, and the involuntary nervous system that controls the heart, lungs and other organs. They treat... WebMar 16, 2016 · Maria Pia Sormani, Sonia Messina, Marika Pane, Adele D'Amico, Giulia Colia, Lavinia Fanelli, Angela Berardinelli, Alice Gardani, Valentina Lanzillotta, Paola D’Ambrosio, Roberta Petillo, [ ... ], Eugenio Mercuri [ view all ] Timed Rise from Floor as a Predictor of Disease Progression in Duchenne Muscular Dystrophy: An Observational Study
WebCV Maria Pia Sormani Maria Pia Sormani is Full Professor of Biostatistics (MED/01) at the University of Genoa since 2024. She has a degree in Biophysics, a master in Medical … WebMaria Pia Sormani, Paolo Bruzzi Summary Background A meta-analysis of randomised trials in relapsing-remitting multiple sclerosis published in 2009 showed a quantitative relation between the treatment eff ects detected on …
WebJul 12, 2024 · July 12, 2024; 99 (2) Research Article Association of No Evidence of Disease Activity With No Long-term Disability Progression in Multiple Sclerosis A Systematic Review and Meta-analysis Dalia Rotstein, Jacqueline Madeleine Solomon, Maria Pia Sormani, Xavier Montalban, Xiang Y. Ye, Dina Dababneh, Alexandra Muccilli, Prakesh Shah
WebApr 18, 2024 · Christine Lebrun Frenay, Aksel Siva, Orhun Kantarci, Christina Azevedo, Maria Pia Sormani, Daniel Pelletier, Darin Okuda First published April 17, 2024, Christine Lebrun Frenay thomas lind knivstaWebJul 8, 2024 · Maria Pia Sormani Department of Health Sciences (DISSAL); Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Ospedale Policlinico San Martino Nicola De Rossi Centro Sclerosi Multipla ASST Spedali Civili di Brescia Irene Schiavetti Department of Health Sciences, University of Genova Luca Carmisciano uhc oxford health insuranceWebMaria Pia Sormani A.O.U. San Martino - IST, Istituto Nazionale Ricerca sul Cancro (GENOVA) 20242024 Research activity per year Overview Fingerprint Network Research output(99) Similar Profiles(1) If you made any changes in Pure these will be visible here soon. Fingerprint Dive into the research topics where Maria Pia Sormani is active. thomas lindnerWebApr 22, 2024 · Dr Maria Pia Sormani, University of Genoa, Italy Conference AAN 2024 MS patients treated with anti-CD20 therapies ocrelizumab and rituximab have an increased risk of severe COVID-19 infection, whereas treatment with interferon or teriflunomide could reduce that risk. uhc overseasWebApr 6, 2024 · Maria Pia Sormani speaks exclusively to VJNeurology, The Video Journal of Neurology. Watch interviews and discussions with Maria Pia Sormani here. thomas lindlbauer gmbhWebApr 6, 2024 · Maria Pia Sormani, PhD, University of Genoa, Genoa, Italy, talks on issues related to COVID-19 data interpretation coming from multiple sclerosis (MS) registries. … thomas lindgren thornton nyWebMaria Pia is a member of the MS Society Clinical Trials Advisory Committee and she is a visiting professor at the Imperial College of London, UK. Over the course of her career, … thomas lindner facebook